Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Int J Med Robot ; 16(1): e2069, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31875349

RESUMEN

BACKGROUND: Renal tumor scoring systems, such as the contact surface area value, aim to assist in predicting outcomes following robotic-assisted partial nephrectomy. The aim of this study is to identify associations between specific postoperative outcomes and the contact surface area of renal masses. METHODS: We analyzed 332 consecutive robotic-assisted partial nephrectomies and calculated contact surface area for renal tumors with the contact surface area formula (CSA = 2πrd), where π ≈ 3.14, r = greatest tumor radius (cm), and d = greatest tumor depth (cm). RESULTS: Higher contact surface area was associated with longer warm ischemia time (P < .001), higher estimated blood loss (P < .001), and longer length of hospital stay (LOS) (P < .001). Higher contact surface area was significantly associated with decreased renal function at 1 day, 1 month, and 6 months following robotic-assisted partial nephrectomy. CONCLUSIONS: Contact surface area is associated with certain outcomes following robotic-assisted partial nephrectomy and may be a useful predictive tool.


Asunto(s)
Neoplasias Renales/cirugía , Nefrectomía/métodos , Procedimientos Quirúrgicos Robotizados/métodos , Anciano , Femenino , Tasa de Filtración Glomerular , Humanos , Neoplasias Renales/patología , Neoplasias Renales/fisiopatología , Tiempo de Internación , Masculino , Persona de Mediana Edad
2.
Scand J Urol ; 53(5): 344-349, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31549563

RESUMEN

Objective: Diagnostic work-up of suspicious renal masses has traditionally been conducted with contrast-enhanced computed tomography (CECT) and/or magnetic resonance imaging (MRI). However, patients who are not candidates for intravenous contrast due to allergy, renal insufficiency, or those on dialysis are discouraged from utilizing traditional contrast imaging due to risks of anaphylaxis, nephrotoxicity, or further kidney damage. We evaluated contrast-enhanced ultrasound (CEUS) in patients on dialysis who would benefit from alternative imaging options to CECT or MRI.Methods: Following IRB approval, nine renal masses from eight patients (aged 54-74 years) with chronic renal insufficiency were evaluated with CEUS and shown to be enhancing after the intravenous administration of ultrasound contrast agent. The ultrasound contrast agent Lumason (Sulfur hexafluoride lipid type-A microspheres, Bracco Diagnostics, Monroe Township, NJ, USA) was utilized. Enhancement was considered present when microbubble contrast agent was visualized within the lesion of interest.Results: Nine CEUS enhancing masses were pathologically examined following laparoscopic radical nephrectomy. Eight of the nine lesions were renal cell carcinoma (two clear cell, four papillary, two cystic). One resected mass was an unspecified benign renal lesion.Conclusions: In this sample of surgically resected tumors, CEUS was effective in characterizing renal lesions as solid neoplasms or complex cystic lesions suspicious for neoplasm-findings which merit further investigation.


Asunto(s)
Carcinoma de Células Renales/diagnóstico por imagen , Carcinoma de Células Renales/cirugía , Medios de Contraste , Fallo Renal Crónico/terapia , Neoplasias Renales/diagnóstico por imagen , Neoplasias Renales/cirugía , Diálisis Renal , Hexafluoruro de Azufre , Anciano , Carcinoma de Células Renales/complicaciones , Humanos , Fallo Renal Crónico/complicaciones , Neoplasias Renales/complicaciones , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Ultrasonografía/métodos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda